← FDA Drug Approvals (Drugs@FDA)
VPRIV
BLA · Biologics License Application · Sponsor: SHIRE HUMAN GENETIC · Approved 2010-02-26
Drug application
- FDA Application #
BLA022575- Application type
- Biologics License Application
- Brand name
- VPRIV
- Generic name
- VELAGLUCERASE ALFA
- Active ingredients
- VELAGLUCERASE ALFA
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- SHIRE HUMAN GENETIC
- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- First approval
- 2010-02-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown